Copyright
©The Author(s) 2024.
World J Clin Cases. Nov 16, 2024; 12(32): 6526-6533
Published online Nov 16, 2024. doi: 10.12998/wjcc.v12.i32.6526
Published online Nov 16, 2024. doi: 10.12998/wjcc.v12.i32.6526
Ref. | Age (years) | Gender | Tumor location | Symptoms and signs | Imaging examinations | Results from histological examination | Immunohistochemical staining | Diagnosis | Treatment |
Kurdoğlu et al[5], 2013 | 29 | Female | Gingiva | Painful buccal gingival swelling and bilateral submandibular lymphadenopathy, no gingival bleeding on probing | Radiological examinations did not show any bone pathology | Monomorphous diffuse infiltrate. Extramedullary myeloblastic malignancy | Positive reaction to CD117 and myeloperoxidase (MPO) | MS | Idarubicin and ARA-C chemotherapy regimen at first treatment phase. Second chemotherapy session 3-5-7 (daunorubicin, etoposide, and ARA-C) |
de Andrade et al[7], 2017 | 24 | Female | Gingiva | Fast growing painful gingival swelling, fever, fatigue, and cervical lymphadenopathy. Bluish swelling on the right posterior lower gingiva exhibiting necrotic surface | Radiographic examination of the mandible showed no bone involvement | Undifferentiated tumor cells with granulocytic appearance | CD99, MPO, and Ki-67 (60%) | MS associated with AML | Chemotherapy, but the patient died of the disease one month later |
Shen et al[2], 2018 | 41 | Female | Gingiva | Gingival swelling. No pain or pyorrhea, a blue-gray discoloration, and gingival masses | In the panoramic radiograph, the palatal bone was intact, and an ill-defined radiolucency was found in the left maxillary edentulous region. In addition, there was generalized mild horizontal alveolar bone loss, and a band-like radiolucent area was found in the alveolar bone crest from the left mandibular canine to the second premolar | Diffuse infiltration in the submucosa with small to medium sized blastic-like cells with increased nucleocytoplasmic ratio, round to oval, irregular nuclei, and fine chromatin. Rare mitotic figures were observed | Positive for myeloperoxidase | MS | Chemotherapy regimen based on anthracycline and cytarabine was instituted. The patient received 3 + 7 induction chemotherapy with doxorubicin and cytarabine, followed by 4 courses of consolidation therapy with cytarabine, L-asparaginase, and methotrexate |
Wang et al[6], 2021 | 82 | Female | Gingiva | Painless swelling on the right maxillary posterior gingiva, tender lump of the right neck, firm mass without purulence | Computed tomography imaging revealed increased fluorodeoxyglucose uptake via the maxillary sinuses bilaterally and the right submandibular lymph node | NA | NA | MS | Radiation therapy (25 Gy over 12 fractions) and subsequent chemotherapy (decitabine) |
65 | Male | Palate | 2.0-0.8 cm craterform ulcer with diffuse erythema, induration, and swelling on the left soft palate, extending into the oropharynx | NA | NA | Bone marrow biopsy confirmed relapsed AML | MS associated with AML | Localized radiation therapy (24 Gy over 14 fractions) and immunotherapy (ipilimumab) | |
58 | Female | Lip | 0.3-0.3 cm indurated, nontender ulcer with surrounding erythema, scaling, and crusting on the midvermillion border of the lower lip | NA | NA | Bone marrow biopsy confirmed relapsed AML | MS associated with AML | Investigational chemotherapeutic drugs, including mitoxantrone, etoposide, and cytarabine and lenalidomide | |
Kole et al[10], 2023 | 29 | Male | Gingiva | Swelling, paresthesia | CECT showed an osteolytic lesion extending from teeth 35 to 37 | Fibro-collagenous tissue infiltrated by nests and trabeculae of intermediate size mononuclear cells having dispersed nuclear chromatin and irregular nuclear margin | Positive for MPO and CD15 | MS | Segmental mandibulectomy |
Li et al[9], 2024 | 32 | Male | Gingiva | Gingival swelling | No extensive bone loss | Diffuse infiltration of abnormal cells | Neoplastic cells were MPO positive, and the Ki-67 staining rate was 80% | MS | Idarubicin (IDA) regimen (IDA hydrochloride 10 mg/1 d-3 d, Cytarabine 100 mg/1 d-7 d) treatment, supplemented with gastric protection and antiemetic therapy |
- Citation: Martínez Nieto M, González Gómez LA, Gómez Mireles JC, Lomelí Martínez SM. Diagnostic and therapeutic challenges of myeloid sarcoma in the oral cavity. World J Clin Cases 2024; 12(32): 6526-6533
- URL: https://www.wjgnet.com/2307-8960/full/v12/i32/6526.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i32.6526